Xvivo Perfusion AB
XVIVO.ST
#5053
Rank
A$1.98 B
Marketcap
$63.12
Share price
0.00%
Change (1 day)
76.97%
Change (1 year)
Categories

Earnings for Xvivo Perfusion AB (XVIVO.ST)

Earnings in 2024 (TTM): A$17.4 Million

According to Xvivo Perfusion AB's latest financial reports the company's current earnings are A$65.99 Million. In 2023 the company made an earning of A$14.28 Million, an increase over its 2022 earnings that were of A$3.48 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Xvivo Perfusion AB from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$17.4 M21.89%
2023 A$14.28 M309.49%
2022 A$3.48 M226.49%
2021 A$1.06 M-110.72%
2020 -A$9.97 Million-1221.07%
2019 A$0.88 M-70.61%
2018 A$3.02 M117.32%
2017 A$1.39 M146.09%
2016 A$0.56 M-61.52%
2015 A$1.46 M-3.88%
2014 A$1.52 M-39.59%
2013 A$2.53 M